Browsing Category
Drug development
Using Biomarkers to Solve Drug Development Problems
Follow this expert-led discussion to learn how biomarkers help drive early clinical trials, and more
Watch this virtual panel discussion, available on demand now
Protein biomarkers offer a dynamic and…
Using real-world evidence to accelerate psychedelic drug development
We are going through a mental health crisis and we urgently need new, more effective therapies.
Psychedelic drugs such as psilocybin, DMT, LSD, MDMA and ketamine have shown promise as potential treatments for a range of mental…
Gilead opens pediatric drug development center in Ireland
The new Global Center of Excellence for Pediatric Drug Development will focus on creating pediatric formulations to treat some of the world's most challenging viral diseases.
.Gilead has opened a global center of excellence for pediatric…
Indivumed Celebrates 20th Anniversary and Success in Individualized Drug Development
Since 2002, Indivumed has converted its unique biobank into an AI-based data analysis platform for target discovery and drug development
Hamburg, Germany, April 5, 2022 /PRNewswire/ -- Indivumed GmbH ("Indivumed") today celebrated the…
Enteris BioPharma highlighted as a Game Changer in drug development and delivery Special feature on…
The article describes the unique features of Peptelligence from Enteris® and ProPerma® peptide and small molecule oral delivery technology
BOONTON, NJ, April 4, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company…
AI Technology to Cut New Drug Development Time in Half
Artificial intelligence technology will be used at every stage of drug development to halve the time needed to discover a new drug, the new head of the Korea AI Center for Discovery and Development said on Wednesday. of drugs.!-->…
It’s time to reform the federal drug development process
Letters submitted by BDN readers are vetted by BDN Opinion Page staff. Send your letters to [email protected]
Kudos to US Senator Angus King, as well as US Senator Susan Collins, for seeking to reform a flawed drug…
“AI technology to halve the development period of new drugs”
Kim Woo-youn, head of the Korea AI Center for Drug Discovery and Development at the Korea Association of Pharmaceutical and Biopharmaceutical Manufacturers, speaks during an online press conference on Wednesday. (Korea Association of…
Synaptogenix will present at the Hanson Wade 10th Annual Neurodegenerative Drug Development Summit
NEW YORK, March 29, 2022 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapies for neurodegenerative disorders, today announced that…
Synaptogenix will present at the Hanson Wade 10th Annual Neurodegenerative Drug Development Summit
NEW YORK, March 29, 2022 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapies for neurodegenerative disorders, today announced that…
Enveric Biosciences expands pipeline of drug development candidates and files new provisional patent…
NAPLES, Florida., March 29, 2022 /PRNewswire/ - Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a Neuroscience Company Developing Next-Generation Psychedelic-Inspired Mental Health Drugs, Announces Filing of Provisional…
Drug Development Services Market Size, Share, Growth Overview, Competitive Analysis
The report organized by Lexis Business Insights on the Global Drug Development Services Market, Shares SWOT Analysis, Key Development Strategies and Forecast to 2027 is the finest manufacture of expertise and trust. The report…
Pfizer discusses using supercomputing and AI for Covid drug development
More than 16 months ago, Pfizer achieved a historic scientific moonshot - the unprecedented development and licensing of a new vaccine against a new virus using methods that had hitherto not been used at large scale in approved drugs.…
A new patient-centric framework informs UCB’s approach to R&D drug development and…
As part of its commitment to creating innovative solutions and transforming the lives of people with serious illnesses, UCB has developed and implemented a new framework focused on its most important stakeholder: the…
Improving the drug development process with more accurate animal models — ScienceDaily
Verifying the efficacy and safety of a drug, clinical trials are a hurdle that must be cleared before a new drug hits the market. Conducting them in humans would be ideal, but due to strict ethical standards, patient availability and…
Experts available to comment on drug development, hospitality
From: Bill Wellock The first cases of COVID in the United States were confirmed in early 2020. Since then, the pandemic has raised questions about health care, education, civil rights and responsibilities, and more.Experts from Florida…
Drug Discovery Informatics Market Forecast by Application (Drug Discovery, Drug Development),…
Drug Discovery Informatics Market
This report presents information related to key drivers, restraints and opportunities, along with a detailed analysis of the drug discovery informatics market share.…
PRIME program benefits drug development, EMA report says
The report describes the positive impact that EMA's PRIority Medicines (PRIME) program has had on the development of medicines for unmet medical needs over the past five years.
In a new report, the European Medicines Agency (EMA) has shown…
Cardior Appoints Heart Disease and RNA Drug Development Experts to Its Scientific Advisory Board to…
HANNOVER, Germany, March 2, 2022--(BUSINESS WIRE)--Cardior Pharmaceuticals, a clinical-stage biotechnology company developing non-coding RNA (ncRNA) therapies for patients with heart disease, today announced the expansion of its scientific…
Cardior Appoints Heart Disease and RNA Drug Development Experts to Its Scientific Advisory Board to…
HANNOVER, Germany--(BUSINESS WIRE)--Cardior Pharmaceuticals, a clinical-stage biotechnology company developing non-coding RNA (ncRNA) therapies for patients with heart disease, today announced the expansion of its Scientific…
Walden Biosciences Announces Participation in the 4th Annual Chronic Kidney Disease (CKD) Drug…
Get instant alerts when news breaks on your stocks. Claim your one week free trial for StreetInsider Premium here.
CAMBRIDGE, Mass., March 01, 2022 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed…
Walden Biosciences Announces Participation in the 4th Annual Chronic Kidney Disease (CKD) Drug…
Walden Biosciences, Inc.CAMBRIDGE, Mass., March 01, 2022 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company focused on transforming the treatment of kidney disease, today announced that…
Sunshine Biopharma expands its anti-coronavirus drug development program by signing a collaboration…
Sunshine Biopharma Inc.MONTREAL, Feb. 25. 28, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: "SBFM" and SBFMW) (the "Company" or "Sunshine Biopharma"), a pharmaceutical company focused on the research, development and…
$23 billion raised for rare disease drug development — Pain News Network
According to the United States Government Accountability Office, the total cost of rare diseases in 2019 reached $966 billion, including both direct medical costs and other indirect expenses such as lost earnings. But funding for…
What are the benefits of in silico toxicology in drug development? – PreScouter
Developing a new drug is an expensive and risky business. Recent estimates indicate that a new drug may cost US$985 million to reach the market. Toxicities are the cause of about 70% of drug failures, a worrying…
Carbon dioxide recycling and efficient drug development — tackling two problems in one…
Using electricity, a new method offers the possibility of recycling CO2 while performing a notoriously difficult reaction, yielding compounds potentially useful for drug development.
Scientists from the Institute for Chemical Reaction…
Stealth BioTherapeutics to Present at Mitochondria Targeted Drug Development Summit
BOSTON, February 22, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving…
What we can learn about cancer drug development from the COVID-19 approach
As an oncologist, I recognize the arduous path to making a new drug. It is a difficult course that is between the bench and the bedside of the patient. Normally, it takes five years or more just to get a new drug to the clinic for…
New FDA program could boost drug development for rare diseases
WASHINGTON — The Food and Drug Administration and drug companies say they hope to improve drug development and approval for rare diseases, the majority of which lack FDA-approved treatments.There are more than 7,000 rare diseases in the…
FDA releases draft guidance on development of non-opioid painkillers
To further address the opioid crisis, the Food and Drug Administration (FDA) released draft guidelines for the development of new painkillers that may reduce opioid consumption and prevent addiction.
In the draft guidelines,…
CytoReason and Pfizer Expand Collaboration to Leverage Machine Learning in Drug Development
TEL AVIV, Israel, February 10, 2022 /PRNewswire/ -- CytoReasona leading developer of computational disease models for effective drug discovery and development, today announced the extension of its collaboration agreement with Pfizer.…
Medicare negotiations will hamper drug development more than previously thought – Endpoints News
Like President Biden Building Back Better Act — and, with it, potentially the Democrats' final blow against major drug pricing reforms for the foreseeable future — remains on life support, the Congressional Budget…
Enveric Biosciences CEO Says Company Will Focus on Drug Development, Drug Discovery and Intellectual…
Tucker noted that through its intellectual property strategy, the company will continue to invent new drug candidates and use internationally filed patent applications to claim compositions, manufacturing methods and clinical uses.
Enveric…
Genetically modified E. coli could improve drug development
Graduate student Huanrong Ouyang collects a single colony of E. coli in a plate to inoculate a liquid culture as part of the production process for natural benzoxazoles. Credit: Texas A&M Engineering
Whether you take a…
New photonic effect could speed up drug development
Nanoscale twisted semiconductors manipulate light in new ways, researchers from the University of Bath and the University of Michigan have shown. The effect could be exploited to accelerate the discovery and development of life-saving…
New effect of photonic technology could speed up drug development
Credit: public domain CC0
Nanoscale twisted semiconductors manipulate light in new ways, researchers from the University of Bath and the University of Michigan have shown. The effect could be exploited to accelerate the discovery…
AI and psychedelics: artificial intelligence helps Mydecine accelerate drug development
Medicine Innovations Group (NEO: MYCO)(OTCMKTS: MYCOF) is turning to artificial intelligence in its quest to develop the most effective psychedelic therapeutic drug offerings on the market today.
It was announced this week that Mydecine…
Mydecine performs innovative modeling of artificial intelligence in supercomputing in the…
The new serotonin receptor model (5-HT2A) will allow the Company to rapidly increase drug analysis by promoting short-term patent applications for new psychedelic molecules.DENVER, January 10, 2022 (GLOBE NEWSWIRE) - Mydecine Innovations…
Mydecine Achieves Innovative Supercomputing Artificial Intelligence Modeling in Psychedelic Drug…
The new serotonin (5-HT) receptor model2A) will allow the Company to rapidly increase the analysis of drugs favoring the filing of patents in the short term for new psychedelic molecules.
Medicine Innovations Group(NEO: MYCO)(OTCMKTS:…
Government reassures scientists about funding for drug development
Dr Monica Musenero, Minister of Science, Technology and Innovation (MoSTI), assured scientists, innovators and drug developers that the government was ready to fund drug development in the country.
Dr Musenero said that because drug…
Artificial intelligence biases impact drug development: AiCure
Artificial intelligence and other forms of advanced data analysis are often seen as completely unbiased and unbiased. However, when the people who set up the processes inadvertently introduce bias, the results can be impacted.Rich…
Lipidor Expands Clinical Program and Announces Investment in New Acne Vulgaris Drug Development…
STOCKHOLM, December 17, 2021 /PRNewswire/ -- Lipidor AB (publ) (Nasdaq First North: LIPI) today announces that it has initiated a preclinical program for a new drug candidate, AKP-08, focused on acne vulgaris (acne). The acne medication…
US Seeks Legislative Pathway for Antibiotic Development
AAmid growing concerns about antibiotic resistance, the US Department of Health and Human Services is set to encourage Congress to create a new incentive program for pharmaceutical companies to develop these life-saving drugs.
In a…
Do not destroy the future development of drugs
As support falters for the massive explosion of large governments that Congress is trying to push through by Christmas, Senate leaders would be wise to take a more efficient, two-party approach to solving problems and modernizing limited…
AWS Helps Pfizer Accelerate Drug Development and Clinical Manufacturing | Taiwan News
AWS Works With Pfizer To Support Faster Innovation And Improved Clinical Manufacturing Operations To Help Develop The Therapies Of Tomorrow…
Pfizer Partners with AWS to Accelerate Drug Development
Pfizer work with Amazon Web Services (AWS) to deploy cloud-based solutions with the potential to improve the way drugs are developed, manufactured and distributed for testing in clinical trials.
For example, Pfizer uses AWS to…
Gilead returns to school with a new program to attract black and Hispanic students to the…
The field of cell and gene therapies (C>) has seen a renaissance, with first-generation commercial therapies such as Kymriah, Yescarta and Luxturna laying the groundwork for an incoming wave of potentially…
Democratize investment in drug development
HUNTINGTON, NY, December 2, 2021 / PRNewswire / - Big Pharma Spends Up To $ 1 billion to fund new drug development - the money comes from exclusive partnerships limited to heavyweight players and taxpayer dollars. "A development of this…
AWS Helps Pfizer Accelerate Drug Development and Clinical Manufacturing
AWS Works With Pfizer To Support Faster Innovation And Improved Clinical Manufacturing Operations To Help Develop The Therapies Of TomorrowSEATTLE, December 02, 2021- (COMMERCIAL THREAD) - Today, Amazon Web Services, Inc. (AWS), a company…
Diamond Therapeutics Announces Four Critical Hires To Further Accelerate Drug Development
Dr. Michael B. McDonnell hired as chief medical officer, Dr. Jeffrey Sprouse as director of pipeline development, Jamie Jarecki Smith as Director of Clinical Operations and Dr. Nancy Raimondi as director of intellectual…
Diamond Therapeutics Announces Four Critical Hires To Further Accelerate Drug Development
Dr. Michael B. McDonnell hired as chief medical officer, Dr. Jeffrey Sprouse as director of pipeline development, Jamie Jarecki Smith as Director of Clinical Operations and Dr. Nancy Raimondi as director of intellectual property
TORONTO,…
Diamond Therapeutics Announces Four Critical Hires To Further Accelerate Drug Development
Dr. Michael B. McDonnell hired as chief medical officer, Dr. Jeffrey Sprouse as director of pipeline development, Jamie Jarecki Smith as Director of Clinical Operations and Dr. Nancy Raimondi as director of intellectual propertyTORONTO,…
Mount Sinai researchers awarded $ 3.15 million to advance multidisciplinary drug development…
Newswise - (New York, NY - November 30, 2021) - National Cancer Institute awarded Mount Sinai researchers $ 3.15 million in grants to assess the potential of a multidisciplinary drug development platform to identify new biological targets…
New approach to machine learning could accelerate drug development
A new type of machine learning that more accurately mimics human learning could accelerate drug development, suggests research from the University of Cambridge.
This new type of artificial intelligence, known as!-->!-->…
23andMe allocates PSPC deal money to drug development
23andMe Holding Co., known for its home health and ancestry testing, is spending the money raised in its recent public list on what could be a…
Diamond Therapeutics Announces Four Critical Hires to Further Accelerate Drug Development
dr. Michael B. McDonnell hired as chief medical officer, Dr. Jeffrey Sprouse as Director of Pipeline Development, Jamie Jarecki-Smith as Director of Clinical Operations and Dr. Nancy Raimondi as Director of Intellectual Property
TORONTO,…
The BBB threat to biosimilar drug development
In 2019, longtime pharmaceutical industry critic Peter Bach spoke the Wall Street newspaper to announce that the United States should throw in the towel at copied versions of the country's most expensive specialty drugs in favor of…
FDA shares research to improve dose selection in pediatric drug development
Posted on November 23, 2021 | Through Mary Ellen Schneider
Dose selection is a significant challenge in pediatric drug development; commonly used kidney function equations…
China makes further progress in developing its COVID-19 drug
To boost its fight against COVID-19, China is accelerating drug development while promoting vaccination.China is developing drugs according to three main strategies to prevent SARS-CoV-2, the virus that causes COVID-19. While the first…
Trevi Therapeutics to Present at 5th Annual Dermatologic Drug Development Summit for Inflammatory…
Development Director Dr Forbes to Present on Nalbuphine ER in Pruritus at the Dermatology Drug Development Summit
Tweet this
Founded in 2011, Trevi Therapeutics is headquartered in New Haven, Connecticut.
About HaduvioHaduvio, an…
Accelerating Drug Development, Health News, ET HealthWorld
through Sanjay VyasIt is no longer news that the COVID19 pandemic has taken the world by surprise. As deadlocks ensued in different countries, scientists and the healthcare community had to keep up with this sudden change and find…
Arovella Therapeutics Ltd Strengthens Drug Development Expertise by Appointing Life Sciences Veteran…
âLiz is one of the few people in the industry whose career spans the continuum of drug development, from early stage research to the commercialization of end products. It's an exciting time in Arovella's evolution, and…
Opioids Market – Increasing research into new developments through new drug development is…
Opioids are psychoactive substances known to be opiates or have opioid-like effects. Fentanyl, alphamethylfentanyl, alfentanil, and sufentanil are some of the examples of synthetic opioids.
Key players in the world opioid market focus…
Thanks to UTEP Research, Door is Open to the “Revolution in Drug Development”
EL PASO, Texas (KTSM) - Chu-Young Kim, Ph.D., University of Texas at El Paso, professor of chemistry and biochemistry, has solved a 30-year-old scientific conundrum - a feat that is documented in the latest edition of Science, one…
“Korea should introduce decentralized clinical trials for post-pandemic drug development”
The Korean government should improve the regulatory regime to introduce decentralized clinical trials (DCTs) to cope with the new drug development environment as seen during the Covid-19 pandemic, foreign experts said on Wednesday.…
Pharmaceutical Companies Integrate Patient Knowledge into Drug Development Process
COSTA MESA, California, November 2, 2021 / PRNewswire / - InVibe Laboratories (http://www.invibe.co), a pioneer in voice technology for market research, and recently included in Inc. 5000's list of fastest growing companies for the…
Lantern Pharma’s Proprietary AI Platform for Precision Oncology Drug Development, RADR®,…
RADR® is also used to: (1) help define and develop combination strategies involving drugs in development by Lantern and existing drugs that are approved for a range of oncology indications; (2) guide the prioritization of potential…
Neuro Vigor and University of Western Australia announce collaborative drug development agreement
The focus will be on new chemical entities to neutralize reactive aldehydes associated with multiple inflammatory and traumatic diseases
HAMMOND, Ind. - Neuro Vigor, a Purdue University-affiliated biotechnology company developing…
MindMed Expands Drug Development Pipeline with Launch of R (-) – MDMA Program
NEW YORK, October 26, 2021 / PRNewswire / - Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED), (DE: MMQ); the "Company"), a leading biotechnology company in the development of psychedelically inspired therapies, is pleased to…
How artificial intelligence can accelerate drug development
Artificial intelligence - the ultimate optimization engine - takes on one of its biggest challenges: unraveling the complicated, slow, and expensive work of drug development.Why is this important: Even though computing power has become…
Digital Revolution Transforming Drug Development: West Pharma
The pharmaceutical industry is rapidly changing in several ways. The potential benefits of this digital evolution, occurring on many levels, include increased ability to meet growing demand for medicines, increased productivity, reduced…
Quris combines AI with ‘patient-on-a-chip’ to speed up drug development and reduce…
The need for animal testing is sad for the drug discovery process, but there is apparently no good alternative to mice, even if they are not particularly accurate human analogues. Quris claims to have the first real option in its…
Raman Spectroscopy Market, 2026 – Increased Focus on Drug Development in Healthcare to Fuel…
DUBLIN, 12 October 2021 / PRNewswire / - The "Raman spectroscopy market with COVID-19 impact analysis by instrument (Raman microscopy, portable and portable Raman), sampling technique (improved surface Raman scattering), application…
CytoReason and Summit Leverage AI in Drug Development Effort
CytoReason, an Israeli company that uses artificial intelligence (AI) to create disease models for drug discovery and development, announced a partnership with Japanese pharmaceutical services company Summit Pharmaceuticals International.…
Scientists discover 14 genes responsible for obesity
The findings could unlink overeating from harmful health effects.
Promising news in the effort to develop drugs to treat obesity: Scientists at the University of Virginia have identified 14 genes that can cause and three that can prevent…
NanoViricides Provides Update on COVID-19 Coronavirus Drug Development Program at Benzinga…
"The only dual-mode drug in development against COVID-19 to block the full lifecycle of the virus for potential treatment"
Tweet this
An updated company presentation that encompasses Dr. Diwan's presentation at the Benzinga conference…
Molnupiravir and Drug Development at Emory | Emory University
Emory University has discovered and advanced the development of some of the world's most important and valuable antiviral drugs, successfully moving treatments from the lab to the bedside.
As one of the nation's leading research…
Experimental approach to drug development indicates better-targeted therapies for…
New research from researchers at the Johns Hopkins Kimmel Cancer Center shows why some drugs in clinical trials to treat a form of acute myeloid leukemia (AML) often fail and demonstrate a way to restore their effectiveness.
The…
Highlights from cancer research and drug development
Image credit: ESMO
Over the past week, the world of cancer research, diagnostics and therapeutics has come together on the European Society for Medical Oncology (ESMO) website to view a wide variety of research!-->!-->…
Biotech CEO Launches Paradigm-Shifting Drug Development Model
Dr. Charles Theuer's "Unnecessary Expense" is published with ForbesBooks
This press release is issued on behalf of ForbesBooks (operated by Advantage Media Group under license).
NEW YORK (September 21, 2021) - Wasteful spending: an…
Amplia Therapeutics Ltd moves from preclinical to drug development with two strong candidates for…
Amplia Therapeutics Ltd (ASX:ATX) has forged ahead, dropping its "pre-clinical stage" status to become a drug development company, with two strong candidates on the verge of two phase 2 clinical studies for pancreatic cancer and pulmonary…
Biotech CEO launches game-changing drug development model
The problem of soaring drug prices in the United States is well documented. Driven by soaring drug development spending, the average cost of $2 billion is offloaded to patients and third-party payers at premium rates, perpetuating…
Lunit AI applied to clinical trial for drug development for the first time – Results presented…
Seoul, South Korea, September 17, 2021 / PRNewswire / - Lunit, a leading provider of medical AI, today announced that its AI for tissue analysis has been applied in a clinical trial for drug development, accurately predicting patient…
SAS and Carolina team up to accelerate development of antiviral drugs
SAS, a leader in analytics and software services, and the University of North Carolina at Chapel Hill partner to transform the drug development process to prevent infectious disease threats from turning into a pandemic like COVID-19.The…
SAS and UNC-Chapel Hill partner to accelerate development of antiviral drugs
CARY & CHAPEL HILL, North Carolina – SAS, a leader in analytics and software services, and the University of North Carolina at Chapel Hill are partnering to transform the drug development process to prevent infectious…
BC platforms to enable longitudinal access to RWD and genomics for drug development in Africa
ZURICH and JOHANNESBURG, September 13, 2021 / PRNewswire / - Today, BC platforms (BCP), a global leader in genomics research, analysis and access to global data, announced a new collaboration with the African Institute of Everyone Genome…
Pediatric drug development: key considerations and challenges
Pediatric drugs, often called "Age-appropriate" or "child-friendly", are essential to the health and well-being of children. Nonetheless, a fundamental principle of any pediatric drug development program is that…
Improving drug development with human liver spheroids
Source: Corning Life Sciences
Sponsored content provided by
Medicines that fail in the later stages of development create one of the biggest challenges in global healthcare. In fact, less than 10% of drugs that enter…
CBO: Proposed Medicare pricing plan could stifle drug development
Posted on August 30, 2021 | Through Jeff Craven
A new drug development model released by the Congressional Budget Office (CBO) estimates that a Medicare drug pricing bill…